AI Verdict
RJET has stronger fundamentals based on our AI analysis.
RLAY vs RJET Fundamental Comparison
| Metric | RLAY | RJET |
|---|---|---|
| Revenue | $15.4M | $1.7B |
| Net Income | $-276.5M | $76.2M |
| Net Margin | -1,800.6% | 4.5% |
| ROE | -48.8% | 5.7% |
| ROA | -44.5% | 2.3% |
| Current Ratio | 22.61x | 0.94x |
| Debt/Equity | 0.00x | 0.77x |
| EPS | $-1.61 | $1.87 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RLAY vs RJET: Frequently Asked Questions
Is RLAY or RJET a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RJET has stronger fundamentals. RLAY is rated SELL (78% confidence) while RJET is rated HOLD (64% confidence). This is not investment advice.
How does RLAY compare to RJET fundamentally?
Relay Therapeutics, Inc. has ROE of -48.8% vs REPUBLIC AIRWAYS HOLDINGS INC.'s 5.7%. Net margins are -1,800.6% vs 4.5% respectively.
Which stock pays higher dividends, RLAY or RJET?
RLAY has a dividend yield of N/A or no dividend while RJET has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RLAY or RJET for long term?
For long-term investing, consider that RLAY has SELL rating with 78% confidence, while RJET has HOLD rating with 64% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RLAY vs RJET?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RLAY vs RJET, the AI consensus favors RJET based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.